logo
Share SHARE
FONT-SIZE Plus   Neg

First Solar To Close Manufacturing Opns. In Frankfurt - Quick Facts

First Solar, Inc. (FSLR) said it is restructuring its operations in response to deteriorating market conditions in Europe and to reduce costs and align its organization with sustainable market opportunities.

As part of the above program, the company will close its manufacturing operations in Frankfurt (Oder), Germany, in the fourth quarter of 2012. Besides, First Solar will indefinitely idle four production lines at its manufacturing center in Kulim, Malaysia, on May 1, 2012.

According to the company, the above actions, combined with other personnel reductions in Europe and U.S., will reduce its global workforce by around 2,000 positions, about 30 percent of the total.

The restructuring initiatives are expected to reduce First Solar's costs by $30-60 million in 2012 and $100-120 million annually going forward. Also, the company's average manufacturing cost is expected to improve to $0.70-$0.72 per watt in 2012 as a result of the changes, below prior expectations of $0.74 per watt. In 2013, the company estimates that average module manufacturing costs will range from $0.60 to $0.64 per watt.

First Solar stated that to achieve cost savings, it will record restructuring and other related charges of $245-370 million, of which $80-120 million are cash expenditures. The company expects to incur charges primarily during the first quarter of 2012 and the rest over the course of this year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Best Buy announced Wednesday its plans to introduce Amazon Alexa and Google Home experiences to its 700 locations across the U.S. starting next month as part of its strategy of pushing smart home technology. A nationwide rollout will be complete by the end of the year. The electronics retailer will expand space at selected stores to better showcase how Amazon's Echo and Google Home interact.. So far this year, 23 novel drugs have already received FDA approval. Now let's take a look at the biotech stocks waiting to hear from the FDA in July. President Donald Trump has continued his assault on one of his favorite targets on Wednesday, lashing out at major media outlets in a series of posts on Twitter. Trump singled out the New York Times and the Washington Post in his tweets, describing the newspapers as "fake news."
comments powered by Disqus
Follow RTT